The European Health Data Spaces Regulation, adopted in 2025, creates an interesting model for mandating access to data relevant to health, including patient records, genomic information, prices, invoices, regulatory and clinical trial data, and other information.

“Secondary uses” of health data are particularly significant, allowing researchers to use data for R&D on new products, training Artificial Intelligence systems, and policy analysis.

The system allows for decentralized, federalized management of data, including registration by researchers, and states that enabled R&D should provide products that are affordable and accessible, in the EU.